Prostate specific gene, PCGEM1, and methods of using PCEGM1...

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S091200, C536S023100, C536S024330, C436S064000

Reexamination Certificate

active

07807373

ABSTRACT:
A nucleic acid sequence that exhibits prostate-specific expression and over-expression in tumor cells is disclosed. The sequence and fragments thereof are useful for detecting, diagnosing, preventing, and treating prostate cancer and other prostate related diseases. The sequence is also useful for measuring hormone responsiveness of prostate cancer cells.

REFERENCES:
patent: 6828429 (2004-12-01), Srivastava et al.
patent: 2001/0053519 (2001-12-01), Fodor et al.
patent: WO 95/19434 (1995-07-01), None
patent: WO 99/00498 (1999-01-01), None
patent: PCT/US00/07906 (2000-05-01), None
Petrovics et al. (Oncogene. Jan. 15, 2004; 23 (2): 605-611).
Fu et al. (DNA Cell Biol. Mar. 2006; 25 (3): 135-141).
Ifere et al. (Recent Pat. DNA Gene Seq. Nov. 2009; 3 (3): 151-163).
GenBank, Accession No. AC013401, GI:6289254, 163807 bp DNA, Nov. 9, 1999.
GenBank, Accession No. AC013401, GI:8050939, 170695 bp DNA, May 24, 2000.
GenBank, Accession No. AC013401, GI:8099084, 172760 bp DNA, May 26, 2000.
GenBank, Accession No. AC013401, GI:8569780, 169700 bp DNA, Jul. 7, 2000.
“AC003046,” EBI Database XP002143197, Dec. 1, 2001.
Srikantan et al., “Structure and Expression of a Novel Prostate Specific Gene: PCGEM1,” Proc. American Assoc. Cancer Research Annual, XP000929230, vol. 40, p. 37 (Mar. 1999).
Bussemakers et al., “A New Prostate-Specific Arker, Strongly Overexpressed in Prostatic Tumors,” Urological Research, XP002074305, vol. 25, No. 1, p. 76 (Feb. 1997).
Wang et al., “Genes Regulated by Androgen in the Rat Ventral Prostate,” Proc. Nat.'l Acad. Sci., U.S.A., vol. 94, pp. 12999-13004 (Nov. 1997).
“AC013401,” EBI Database XP002143200, Apr. 16, 2005.
Srikantan et al., “PCGEM1, a Prostate-Specific Gene, Is Overexposed in Prostate Cancer,” Proc. Nat'l. Acad. Sci., vol. 97, No. 22, pp. 12216-12221 (Oct. 24, 2000).
Srikantan et al., Identification of Prostate Cancer Associated Novel Gene Expression Alterations, Proc. American Assoc. Cancer Research, vol. 39, p. 362 (Mar. 1998).
Srikantan et al., Identification of Prostate Cancer Associated Novel Gene Expression Alterations,USUHS Research Day-Graduate Student Colloquium, p. 164 (Apr. 1-2, 1998).
Srikantan et al., Identification of Prostate Cancer Associated Novel Gene Expression Alterations, J. Urology, AUA 93rd Annual Meeting, p. 40 (May 30-Jun. 4, 1998).
Petrovics, et al., Oncogene, vol. 23, pp. 605-611 (2004).
Genbank, Accession No. AC003046, GI:2583140, 229335 bp DNA, Nov. 3, 1997.
Moreno, J.G. et al., “Detection of Hematogenous Micrometastasis in Patients with Prostate Cancer,” Cancer Research, 52:6110-6112 (Nov. 1992).
Dixon et al., Cancer Chemother. Pharmacol., (1999) 43(Suppl.):S78-S84.
Genbank, Accession No. AF099810, GI:3800891, 193824 bp DNA, Oct. 28, 1998.
Genbank, Accession No. AC006925, GI:4417322, 176186 bp DNA, Mar. 16, 1999.
Office Action dated Dec. 20, 2005, from European Application No. 00 918 373.2.
Office Action dated Jul. 19, 2007, from European Application No. 00 918 373.2.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Prostate specific gene, PCGEM1, and methods of using PCEGM1... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Prostate specific gene, PCGEM1, and methods of using PCEGM1..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prostate specific gene, PCGEM1, and methods of using PCEGM1... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4232354

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.